$6M Takeda Verdict Reinstated In 1st Actos Cancer Trial
By Kurt Orzeck (July 16, 2015, 3:54 PM EDT) -- A California state appeals court on Thursday reinstated a $6.5 million jury award against Japan's Takeda Pharmaceutical Co. Ltd. in the first product liability trial over claims its diabetes drug Actos caused cancer, a verdict the trial judge tossed more than two years ago.
Actos was once the world's top-selling diabetes drug, reaching sales of $4.5 billion for the fiscal year ended March 2011. (Credit: Getty) The appeals court found that the lower court erred when it struck as "inherently unreliable" expert testimony linking Actos to a 79-year-old old man's terminal bladder cancer and reversed a Los Angeles jury's multimillion-dollar verdict for the man...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!